Synthesis, radiolabeling and biological evaluation of propylene amine oxime complexes containing nitrotriazoles as hypoxia markers

Molecules

Volumn 17, Issue 6, 2012, Pages 6808-6820

  Huang, Huafan ^a   Mei, Lei ^a   Chu, Taiwei ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

Cellular accumulation; Hypoxia marker; Nitrotriazole; Technetium 99m; Tumor

Indexed keywords

BIOLOGICAL MARKER; DRUG DERIVATIVE; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; TECHNETIUM COMPLEX; TRIAZOLE DERIVATIVE;

ANIMAL; ARTICLE; CELL HYPOXIA; CHEMISTRY; ISOTOPE LABELING; MALE; METABOLISM; MOUSE; QUALITY CONTROL; SYNTHESIS; TEMPERATURE; TISSUE DISTRIBUTION; TUMOR CELL LINE;

ANIMALS; BIOLOGICAL MARKERS; CELL HYPOXIA; CELL LINE, TUMOR; ISOTOPE LABELING; MALE; MICE; ORGANOTECHNETIUM COMPOUNDS; QUALITY CONTROL; TECHNETIUM TC 99M EXAMETAZIME; TEMPERATURE; TISSUE DISTRIBUTION; TRIAZOLES;

EID: 84862986523     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules17066821     Document Type: Article

References (27)

1. Gray, L. H.; Conger, A. D.; Ebert, M.; Hornsey, S.; Scott, O. C. A. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy. Br. J. Radiol. 1953, 26, 638-648.
2. Nunn, A.; Linder, K.; Strauss, H. W. Nitroimidazoles and imaging hypoxia. Eur. J. Nucl. Med. 1995, 22, 265-280.
3. 18F]fluoromisonidazole: A pretherapy study of 37 patients. Int. J. Radiat. Oncol. Biol. Phys. 1996, 36, 417-428.
4. Saita, K.; Chen, M.; Spratt, N. J.; Porritt, M. J.; Liberatore, G. T.; Read, S. J.; Levi, C. R.; Donnan, G. A.; Ackermann, U.; Tochon-Danguy, H. J.; et al. Imaging the ischemic penumbra with 18F-fluoromisonidazole in a rat model of ischemic stroke. Stroke 2004, 35, 975-980. (Pubitemid 38419813)
5. Martin, G. V.; Caldwell, J. H.; Graham, M. M.; Grierson, J. R.; Kroll, K.; Cowan, M. J.; Lewellen, T. K.; Rasey, J. S.; Casciari, J. J.; Krohn, K. A. Noninvasive detection of hypoxic myocardium using fluorine-18-fluoromisonidazole and positron emission tomography. J. Nucl. Med. 1992, 33, 2202-2208.
6. 99mTc-labeling studies of a modified metronidazole and its biodistribution in tumor bearing animal models. Nucl. Med. Biol. 2003, 30, 127-134. (Pubitemid 36293713)
7. 2+ complex of metronidazole xanthate as a potential agent for targeting hypoxia. Bioorg. Med. Chem. Lett. 2005, 15, 3398-3401. (Pubitemid 40835744)
8. Dobrowsky, W.; Huigol, N. G.; Jayatilake, R. S.; Kizilbash, N. I. A.; Okkan, S.; Kagiya, V. T.; Tatsuzaki, H. AK-2123 (Sanazol) as a radiation sensitizer in the treatment of stage III cervical cancer: Results of an IAEA multicentre randomised trial. Radiother. Oncol. 2007, 82, 24-29. (Pubitemid 46097134)
9. Huilgol, N. G.; Chatterjee, N.; Mehta, A. R. An overview of the initial experience with AK-2123 as a hypoxic cell sensitizer with radiation in the treatment of advanced head and neck cancers. Int. J. Radiat. Oncol. Biol. Phys. 1996, 34, 1121-1124. (Pubitemid 26106231)
10. Sugie, C.; Shibamoto, Y.; Ito, M.; Ogino, H.; Suzuki, H.; Uto, Y.; Nagasawa, H.; Hori, H. Reevaluation of the radiosensitizing effects of sanazole and nimorazole in vitro and in vivo. J. Radiat. Res. 2005, 46, 453-459. (Pubitemid 43268410)
11. Murugesan, S.; Shetty, S. J.; Noronha, O. P. D.; Samuel, A. M.; Srivastava, T. S.; Nair, C. K.; Kothari, L. Technetium-99m-cyclam AK 2123: A novel marker for tumor hypoxia. Appl. Radiat. Isot. 2001, 54, 81-88.
12. Das, T.; Chakraborty, S.; Banerjee, S.; Mukherjee, A.; Samuel, G.; Sarma, H. D.; Nair, C. K. K.; Kagiya, V. T.; Venkatesh, M. Preparation and preliminary biological evaluation of a 177Lu labeled sanazole derivative for possible use in targeting tumor hypoxia. Bioorg. Med. Chem. 2004, 12, 6077-6084. (Pubitemid 39440448)
13. 99mTc labeled nitrobenzoimidazole and nitrotriazole as tumor hypoxia markers. Bioorg. Med. Chem. Lett. 2006, 16, 1831-1833. (Pubitemid 43267360)
14. 18F]FMISO as hypoxia-selective tracer for PET. Nucl. Med. Biol. 2010, 37, 565-575.
15. Jurisson, S. S.; Lydon, J. D. Potential technetium small molecule radiopharmaceuticals. Chem. Rev. 1999, 99, 2205-2218.
16. Linder, K. E.; Chan, Y. W.; Cyr, J. E.; Malley, M. F.; Nowotnik, D. P.; Nunn, A. D. TcO (PnAO-1-(2-nitroimidazole)) [BMS-181321], a new technetium-containing nitroimidazole complex for imaging hypoxia: synthesis, characterization, and xanthine oxidase-catalyzed reduction. J. Med. Chem. 1994, 37, 9-17. (Pubitemid 24058808)
17. Ballinger, J. R.; Kee, J. W. M.; Rauth, A. M. In vitro and in vivo evaluation of a technetium-99mlabeled 2-nitroimidazole (BMS181321) as a marker of tumor hypoxia. J. Nucl. Med. 1996, 37, 1023-1031. (Pubitemid 126447145)
18. 99mTc-labeled 2-nitroimidazole for imaging hypoxia in tumors. J. Nucl. Med. 2000, 41, 169-176. (Pubitemid 30046699)
19. 99mTc-labeled bisnitroimidazole propylene amine oxime complexes. Bioorg. Med. Chem. Lett. 2012, 22, 172-177.
20. 99mTc brain imaging agents. J. Med. Chem. 1985, 28, 1280-1284. (Pubitemid 16252430)
21. Mastrostamatis, S. G.; Papadopoulos, M. S.; Pirmettis, I. C.; Paschali, E.; Varvarigou, A. D.; Stassinopoulou, C. I.; Raptopoulou, C. P.; Terzis, A.; Chiotellis, E. Tridentate ligands containing the SNS donor atom set as a novel backbone for the development of technetium brain-imaging agents. J. Med. Chem. 1994, 37, 3212-3218. (Pubitemid 24325033)
22. Edwards, D. I. Nitroimidazole drugs-Action and resistance mechanisms. 1. Mechanisms of action. J. Antimicrob. Chemother. 1993, 31, 9-20. (Pubitemid 23078062)
23. Larina, L.; Lopyrev, V. Nitroazoles: Synthesis, Structure and Applications, 1st ed.; Springer Press: New York, NY, USA, 2009; p. 284.
24. Ramalingam, K.; Raju, N.; Nanjappan, P.; Nowotnik, D. P. Synthesis of nitroimidazole substituted 3, 3, 9, 9-tetramethyl-4, 8-diazaundecane-2, 10-dione dioximes (propylene amine oximes, PnAOs): Ligands for technetium-99m complexes with potential for imaging hypoxic tissue. Tetrahedron 1995, 51, 2875-2894.
25. Dearling, J. L. J.; Lewis, J. S.; Mullen, G. E. D.; Rae, M. T.; Zweit, J.; Blower, P. J. Design of hypoxia-targeting radiopharmaceuticals: Selective uptake of copper-64 complexes in hypoxic cells in vitro. Eur. J. Nucl. Med. 1998, 25, 788-792. (Pubitemid 28377043)
26. Dearling, J. L. J.; Lewis, J. S.; Mullen, G. E. D.; Welch, M. J.; Blower, P. J. Copper bis (thiosemicarbazone) complexes as hypoxia imaging agents: structure-activity relationships. J. Biol. Inorg. Chem. 2002, 7, 249-259. (Pubitemid 36056377)
27. Zhang, X. G.; Melo, T.; Rauth, A. M.; Ballinger, J. R. Cellular accumulation and retention of the technetium-99m-labelled hypoxia markers BRU59-21 and butylene amine oxime. Nucl. Med. Biol. 2001, 28, 949-957. (Pubitemid 33050028)